Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qun Xiang

Showing results (141-150 of 177) with videos related to

Pageof 18
Sort By:
Oral Oncology|December 20, 2025
Development of a simplified scoring system for MRI-detected retropharyngeal lymph node features to optimize AJCC 9th edition N classification in nasopharyngeal carcinomaQin Liu, Jing-Ni Wei, Jia-Yu Zhou, et al.
Therapeutic Advances in Medical Oncology|July 27, 2018
The plasma Epstein-Barr virus DNA level guides precision treatment for nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: a large population-based cohort study from an endemic areaHu Liang, Xing Lv, Lin Wang, et al.
International Journal of Biological Sciences|September 17, 2019
<i>CHL1</i> suppresses tumor growth and metastasis in nasopharyngeal carcinoma by repressing PI3K/AKT signaling pathway via interaction with Integrin β1 and MerlinJuan Chen, Chen Jiang, Li Fu, et al.
JAMA Oncology|February 17, 2022
Effect of Capecitabine Maintenance Therapy Plus Best Supportive Care vs Best Supportive Care Alone on Progression-Free Survival Among Patients With Newly Diagnosed Metastatic Nasopharyngeal Carcinoma Who Had Received Induction Chemotherapy: A Phase 3 Randomized Clinical TrialGuo-Ying Liu, Wang-Zhong Li, De-Shen Wang, et al.
Nature Communications|February 3, 2024
Camrelizumab and apatinib plus induction chemotherapy and concurrent chemoradiotherapy in stage N3 nasopharyngeal carcinoma: a phase 2 clinical trialHu Liang, Yao-Fei Jiang, Guo-Ying Liu, et al.
Cell Death & Disease|June 2, 2017
Promoting tumorigenesis in nasopharyngeal carcinoma, NEDD8 serves as a potential theranostic targetPing Xie, Jun-Ping Yang, Yun Cao, et al.
Eclinicalmedicine|August 18, 2023
Efficacy and safety of sintilimab plus bevacizumab in metastatic nasopharyngeal carcinoma after failure of platinum-based chemotherapy: an open-label phase 2 studyNian Lu, Yao-Fei Jiang, Wei-Xiong Xia, et al.
Oral Oncology|May 18, 2012
A randomized trial of induction chemotherapy plus concurrent chemoradiotherapy versus induction chemotherapy plus radiotherapy for locoregionally advanced nasopharyngeal carcinomaPei-Yu Huang, Ka-Jia Cao, Xiang Guo, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 14, 2020
MRI-detected residual retropharyngeal lymph node after intensity-modulated radiotherapy in nasopharyngeal carcinoma: Prognostic value and a nomogram for the pretherapy prediction of itWang-Zhong Li, Guo-Ying Liu, Lan-Feng Lin, et al.
Theranostics|July 9, 2019
Polo-Like Kinase 1 phosphorylates and stabilizes KLF4 to promote tumorigenesis in nasopharyngeal carcinomaJia Mai, Zhuo-Yan Zhong, Gui-Fang Guo, et al.
Pageof 18

Showing results (141-150 of 177) with videos related to

Sort By:
Pageof 18
Oral Oncology|December 20, 2025
Development of a simplified scoring system for MRI-detected retropharyngeal lymph node features to optimize AJCC 9th edition N classification in nasopharyngeal carcinomaQin Liu, Jing-Ni Wei, Jia-Yu Zhou, et al.
Therapeutic Advances in Medical Oncology|July 27, 2018
The plasma Epstein-Barr virus DNA level guides precision treatment for nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: a large population-based cohort study from an endemic areaHu Liang, Xing Lv, Lin Wang, et al.
International Journal of Biological Sciences|September 17, 2019
<i>CHL1</i> suppresses tumor growth and metastasis in nasopharyngeal carcinoma by repressing PI3K/AKT signaling pathway via interaction with Integrin β1 and MerlinJuan Chen, Chen Jiang, Li Fu, et al.
JAMA Oncology|February 17, 2022
Effect of Capecitabine Maintenance Therapy Plus Best Supportive Care vs Best Supportive Care Alone on Progression-Free Survival Among Patients With Newly Diagnosed Metastatic Nasopharyngeal Carcinoma Who Had Received Induction Chemotherapy: A Phase 3 Randomized Clinical TrialGuo-Ying Liu, Wang-Zhong Li, De-Shen Wang, et al.
Nature Communications|February 3, 2024
Camrelizumab and apatinib plus induction chemotherapy and concurrent chemoradiotherapy in stage N3 nasopharyngeal carcinoma: a phase 2 clinical trialHu Liang, Yao-Fei Jiang, Guo-Ying Liu, et al.
Cell Death & Disease|June 2, 2017
Promoting tumorigenesis in nasopharyngeal carcinoma, NEDD8 serves as a potential theranostic targetPing Xie, Jun-Ping Yang, Yun Cao, et al.
Eclinicalmedicine|August 18, 2023
Efficacy and safety of sintilimab plus bevacizumab in metastatic nasopharyngeal carcinoma after failure of platinum-based chemotherapy: an open-label phase 2 studyNian Lu, Yao-Fei Jiang, Wei-Xiong Xia, et al.
Oral Oncology|May 18, 2012
A randomized trial of induction chemotherapy plus concurrent chemoradiotherapy versus induction chemotherapy plus radiotherapy for locoregionally advanced nasopharyngeal carcinomaPei-Yu Huang, Ka-Jia Cao, Xiang Guo, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 14, 2020
MRI-detected residual retropharyngeal lymph node after intensity-modulated radiotherapy in nasopharyngeal carcinoma: Prognostic value and a nomogram for the pretherapy prediction of itWang-Zhong Li, Guo-Ying Liu, Lan-Feng Lin, et al.
Theranostics|July 9, 2019
Polo-Like Kinase 1 phosphorylates and stabilizes KLF4 to promote tumorigenesis in nasopharyngeal carcinomaJia Mai, Zhuo-Yan Zhong, Gui-Fang Guo, et al.
Pageof 18